Logo for DBV Technologies S.A.

DBV Technologies Investor Relations Material

Latest events

Logo for DBV Technologies S.A.

Q3 2023

DBV Technologies
Logo for DBV Technologies

Q3 2023

31 Oct, 2023
Logo for DBV Technologies

Q2 2023

31 Jul, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
DBV Technologies, S.A. is a clinical-stage biopharmaceutical company engaged in the research and development of epicutaneous immunotherapy (EPI) products to treat cancer and dermatology. The company's EPI technology platform includes monoclonal antibodies, passive transport devices using microelectrode arrays, and a wide variety of fully human anti-cancer antibodies